These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Mapping of a B-cell epitope present in the neuraminidase of Trypanosoma cruzi. Prioli RP; Ortega-Barria E; Mejia JS; Pereira ME Mol Biochem Parasitol; 1992 May; 52(1):85-96. PubMed ID: 1378212 [TBL] [Abstract][Full Text] [Related]
29. Thrombin interaction with platelet membrane glycoprotein Ib. Jandrot-Perrus M; Bouton MC; Lanza F; Guillin MC Semin Thromb Hemost; 1996; 22(2):151-6. PubMed ID: 8807712 [TBL] [Abstract][Full Text] [Related]
30. Crystallographic structures of thrombin complexed with thrombin receptor peptides: existence of expected and novel binding modes. Mathews II; Padmanabhan KP; Ganesh V; Tulinsky A; Ishii M; Chen J; Turck CW; Coughlin SR; Fenton JW Biochemistry; 1994 Mar; 33(11):3266-79. PubMed ID: 8136362 [TBL] [Abstract][Full Text] [Related]
31. Structure and function of the human platelet thrombin receptor. Studies using monoclonal antibodies directed against a defined domain within the receptor N terminus. Brass LF; Vassallo RR; Belmonte E; Ahuja M; Cichowski K; Hoxie JA J Biol Chem; 1992 Jul; 267(20):13795-8. PubMed ID: 1321125 [TBL] [Abstract][Full Text] [Related]
32. Proteolysis of the exodomain of recombinant protease-activated receptors: prediction of receptor activation or inactivation by MALDI mass spectrometry. Loew D; Perrault C; Morales M; Moog S; Ravanat C; Schuhler S; Arcone R; Pietropaolo C; Cazenave JP; van Dorsselaer A; Lanza F Biochemistry; 2000 Sep; 39(35):10812-22. PubMed ID: 10978167 [TBL] [Abstract][Full Text] [Related]
33. Protease-activated receptor-1 can mediate responses to SFLLRN in thrombin-desensitized cells: evidence for a novel mechanism for preventing or terminating signaling by PAR1's tethered ligand. Hammes SR; Coughlin SR Biochemistry; 1999 Feb; 38(8):2486-93. PubMed ID: 10029543 [TBL] [Abstract][Full Text] [Related]
37. Thrombin receptor activation by thrombin and receptor-derived peptides in platelet and CHRF-288 cell membranes: receptor-stimulated GTPase and evaluation of agonists and partial agonists. Seiler SM; Peluso M; Tuttle JG; Pryor K; Klimas C; Matsueda GR; Bernatowicz MS Mol Pharmacol; 1996 Jan; 49(1):190-7. PubMed ID: 8569706 [TBL] [Abstract][Full Text] [Related]
38. Localization and characterization of an alpha-thrombin-binding site on platelet glycoprotein Ib alpha. De Marco L; Mazzucato M; Masotti A; Ruggeri ZM J Biol Chem; 1994 Mar; 269(9):6478-84. PubMed ID: 8119999 [TBL] [Abstract][Full Text] [Related]
39. Constitutive transactivation by the thyroid hormone receptor and a novel pattern of activity of its oncogenic homolog v-ErbA in Xenopus oocytes. Nagl SB; Nelson CC; Romaniuk PJ; Allison LA Mol Endocrinol; 1995 Nov; 9(11):1522-32. PubMed ID: 8584030 [TBL] [Abstract][Full Text] [Related]
40. The N-terminal thrombin receptor fragment SFLLRN, but not catalytically inactive thrombin-derived agonists, activate U937 human monocytic cells: evidence for receptor hydrolysis in thrombin-dependent signalling. Joseph S; MacDermot J Biochem J; 1993 Mar; 290 ( Pt 2)(Pt 2):571-7. PubMed ID: 8383967 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]